Starpharma gets US patent for use of VivaGel for protection against STIs
Saturday, September 26, 2009 15:00 IST Melbourne
Starpharma Holdings Limited has received notification of the grant in the US of a key patent specifically relating to the use of SPL7013 to protect against sexually transmitted infections (STIs).